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Abstract
Hepatitis C (HCV) is a blood borne virus that affects the liver. It has become
one of the most widespread blood borne viruses in Australia, now reaching epidemic
proportions within the population. Given that HCV is a chronic long-term illness, with
long term effects, a positive diagnosis potentially impacts on various aspects of a
person's life. The aim of this paper was to review HCV related research to examine
what it is like for people living with the virus and the possible personal and social
impacts of a positive diagnosis. The nature of HCV, including current incidence and
prevalence rates, natural history, transmission and treatment are discussed. Recent
quantitative and qualitative research focusing on the various impacts of hepatitis C and
the subsequent effects on quality of life are then critically explored. While formal
research in this area is relatively limited, the available evidence suggests that
individuals living with HCV experience a wide range of personal and social impacts,
resulting in a significant decline in quality of life. The need for further understanding of
this serious public health issue is discussed and possible directions for future research
are identified.
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Living With Hepatitis C : A Literature Review
1. Introduction
Since it's identification in 1989, hepatitis C has become one of the most
widespread blood-borne viruses throughout Australia (Department of Health and Aged
Care (DHAC), 2000). It is thought that the hepatitis C virus (HCV) has existed since
the early 1970s, but was known only as 'non A - non B' hepatitis for approximately
twenty years (Standing Committee on Social Issues (SCSI), 1998). The nature of the
hepatitis C virus is unique in that there is a considerable lag between the time of
infection and the onset of consequences (SCSI, 1998). Therefore, the seriousness of the
virus and the extent to which it affects the population is only just beginning to be
recognised. It is now understood that hepatitis C has reached epidemic proportions and
has become a major public health issue in Australia (DHAC, 2000).
While there has been a large amount of research on the epidemiology (Dolan,
2000; Dore, 2000a), prevention (Wodak & Crofts, 1996) and treatment (Sievert &
Korevaar, 1999) of hepatitis C, relatively few studies have documented the extent to
which a positive diagnosis impacts on various aspects of a person's life (Garrett &
Conrad, 2001; Burrows & Bassett, 1996; Crofts, Louie & Loff, 1997). Hepatitis C is a
chronic illness for the majority of people, thus in order to provide adequate care and
support, it is imperative to understand the meaning that a positive diagnosis has for the
person (Lin, Barker & Batey, 1999; Loveday, Deakin & Neophyton, 1999).
Furthermore, while it is important to understand how the medical aspect of the virus
affects the person, the emotional, psychological and social components also need to be
acknowledged (Hepworth & Krug, 1999; Strauss, Corbin, Fagerhaugh, Glaser, Maines,
Suczek & Wiener, 1984).
This paper is a review of the literature relevant to hepatitis C and the possible
personal and social impacts of a positive diagnosis. Firstly, a profile of hepatitis C,
including, current incidence and prevalence rates, natural history, transmission and
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treatment will be discussed. Research focusing on the various impacts of hepatitis C
and the subsequent effects on quality oflife will then be critically explored. Finally,
gaps in the literature will be identified and future directions for research will be
acknowledged.
2. Hg,atitis C: A Profile of the Virus
Hepatitis means inflammation of the liver, which can cause damage to liver cells
(Hepatitis C Council of WA (HCCWA), 1998). There are several different causes of
hepatitis, including chemicals, alcohol, drugs, impaired immune systems and viral
infections such as hepatitis A (HAV), hepatitis B (HBV) and hepatitis C (HCV)
(DHAC, 2000; HCCWA, 1998). A laboratory test for hepatitis C has been available
since 1990 and it has since been discovered that there are at least nine different strains
ofHCV with which people can become co-infected (Australian National Council on
AIDS and Related Diseases (ANCARD), 1998; DHAC, 2000; HCCWA, 1 998).
Currently there is no vaccine available for hepatitis C so for many people the virus is a
life long condition (Lowe & Cotton, 1 999).
2.1 Prevalence and Incidence
Prevalence refers to the total number of people in a population who have the
virus at a specific point in time (SCSI, 1 998). Current estimates suggest that over
200,000 people have been infected with hepatitis C in Australia (DHAC, 2000;
ANCARD, 1 998). Prevalence has also been cited as approximately 1 % of the
population which equates to one person in every 100, being HCV positive (HCCWA,
1998). The Hepatitis C Sub-Committee suggest that if current transmission rates
continue, prevalence figures are likely to double by the year 201 0 (ANCARD, 1 998).
Incidence refers to the number of people who are newly infected with hepatitis
C each year and reflects the rate at which the disease occurs (DHAC, 2000). Current
estimates of incidence rates suggest that approximately 1 1,000 new HCV infections
occur each year (DHAC, 2000). Since the screening of blood supplies in 1 990,
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approximately 90% of these new infections are believed to be from injecting drug use
(Lowe & Cotton, 1999; ANCARD, 1998).
In many respects hepatitis C is a relatively new virus, which is reflected by the
difficulty in obtaining accurate figures on the prevalence and incidence of the disease
(SCSI, 1998). Prevalence studies to date have obtained data by screening selected sub
groups, none of which can be described as a representative sample of the general
community (ANCARD, 1998). Instead, the prevalence of hepatitis C has been
estimated in sub-populations including injecting drug users (Selvey, Denton & Plant,
1997; Wodak & Crofts, 1996), blood donors (Archer et al., 1992) and prisoners (Dolan,
2000).
Most prevalence studies of hepatitis C amongst injecting drug users have
reported consistent rates of 50% - 70% since the 1970's (ANCARD, 1998), however
some studies have reported figures as high as 94% (Gaughwin, Dodding & Ali, 1994).
Blood donors have much lower prevalence rates, with an average of 1% of the
population testing positive for hepatitis C (ANCARD, 1998). Studies within prisons
have reported higher prevalence rates of approximately 35% amongst general prisoners
and up to 80% amongst prisoners who are also injecting drug users (Dolan, 2000).
It is acknowledged that a number of methodological problems associated with
HCV epidemiology means that estimated prevalence and incidence rates should be
interpreted with caution (Lowe & Cotton, 1999). There are limitations with current
testing technology in that tests do not distinguish between acute, newly acquired
infections and chronic, long-term infections (DHAC, 2000). Therefore, accurate and
reliable data concerning incidence rates of hepatitis C in Australia are very difficult to
estimate (ANCARD, 1998). Furthermore, due to the absence of representative
population based information, it is still uncertain about the actual number of people who
are HCV positive (SCSI, 1998). Despite numerous studies of hepatitis C within specific
populations, it is clear that research is still needed to monitor prevalence and incidence
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within the general community if a clearer picture of the epidemic is to evolve (SCSI,
1 998).
2.2 Natural History of Hepatitis C
It has been noted that hepatitis C attacks and damages liver cells, however the
extent of damage and the natural history of the disease can vary between people
(HCCWA, 1 998). The initial phase of infection is described as acute hepatitis C which
occurs approximately 6 to 10 weeks after exposure and usually lasts between 2 and 6
months (Marinos, Pirola & Locarnini, 1 999). During this time levels of the virus are
high, however acute hepatitis C appears to be symptomatic in only 25% of cases, so
most of the time the acute phase goes unnoticed (Marinos, Pirola & Locamini, 1 999;
HCCWA, 1 998).
Although the body produces antibodies to fight the virus, it is not eliminated in
the majority of cases and the infection becomes chronic (HCCWA, 1998). Chronic
hepatitis C infection is defined as persisting for more than six months and refers
specifically to the duration of the virus and not the severity of the disease (Lin, Barker
& Batey, 1 999). Chronic hepatitis C infection can lead to a wide spectrum of liver
disease ranging from various levels of damage through to cirrhosis (scarring of the
liver), however HCV is a very slow acting virus and can take up to 30 years to cause
damage (Lin, Barker & Batey, 1999).
In a recent review of studies concerning the natural history of hepatitis C, Dore
(2000a) reported the following outcomes if 100 people were infected with the virus.
Approximately 1 5 to 35 people will clear the virus within 2 to 6 months of infection,
thus only experiencing the acute phase of hepatitis C. However, clearance of the virus
does not lead to immunity and these people can be re-infected if they are subsequently
exposed to the virus. The remaining 65 to 85 people will not eliminate the virus and
will develop chronic hepatitis C infection. Some of these people will never develop any
liver damage and others will experience some level of damage after an average of 13
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years (HCCWA, 1 998). It is believed that of the people who develop chronic HCV
infection, 5 to 10 will have progressed to cirrhosis after an average of twenty years,
with increased risk for those with sufficient alcohol consumption or co-infection with
HIV or hepatitis B. About 3 to 5 people with hepatitis C related cirrhosis will be at risk
of liver failure or hepatocellular carcinoma (HCC) after thirty to forty years of infection.
One of the difficulties in predicting the progression of hepatitis C, is that once
chronic infection has been established, the course of the virus appears to differ
enormously among individuals (Dore, 2000a). Furthermore, the factors that influence
clearance ofHCV or the progression to cirrhosis or advanced liver disease are not
clearly understood (Dore, 2000a; ANCARD, 1 999). The lack of clinical illness for the
majority of people with newly acquired HCV means that most people do not know they
are infected, resulting in a small sample of cases and limited follow-up in many studies
ofHCV progression (Dore, 2000a).
It is also acknowledged that a major limitation of natural history studies is that
most of the data comes from those who have acquired their infection via blood
transfusions (Dore, 2000a; ANCARD, 1 999). It is possible that the progression of
hepatitis C may be different in those who have post transfusion infection as opposed to
the more common community-acquired infection (injecting drug use) (ANCARD,
1 999). Therefore, as most hepatitis C infections in Australia are a result of injecting
drug use, research on the natural history of the virus may be invalid (Dore, 2000a).
Dore (2000a) also notes that a large number of studies are conducted on selective clinic
based groups such as liver clinics, suggesting there needs to be more data made
available from representative population based research.
2.3 Transmission
Hepatitis C is a blood-borne virus that requires blood-to-blood contact for
infection to occur (HCCWA, 1 998). It is relatively robust and only minute amounts of
blood are needed to infect someone, during both the acute or chronic phases of the virus

Living With Hepatitis C 8

(HCCWA, 1998). Studies of hepatitis C risk factors have suggested that around 80% of
people that are positively diagnosed in Australia, were exposed through injecting drug
use (Dore, Pritchard-Jones, Fisher & Law, 1999; ANCARD, 1998). Approximately 7%
acquired hepatitis C through the receipt of blood or blood products, and 13% were
infected via other routes such as tattoos and needlestick injuries (ANCARD, 1998).
The various routes through which hepatitis C is transmitted will now be examined
further.
2.3.1. Injecting drug use.
Sharing needles and syringes, as well as other drug injecting equipment
including water, swabs and spoons, poses the highest risk of transmitting or acquiring
hepatitis C (Dore et al., 1999; MacDonald & Wodak, 1999; HCCWA, 1998). The
highly infectious, robust nature of the virus and the large pool of infection among
injecting drug users, are factors that influence the high level of risk associated with
injecting behaviour (Wodak & Crofts, 1996). Prevalence of hepatitis C is strongly
associated with the duration of injecting, with the rates being as high as 40% after two
years of injecting and approximately 90% to 100% for those who have injected for more
than ten years (Crofts et al., 1993). Although there has been some recent evidence
suggesting a decrease in the sharing of injecting equipment and therefore rate of
transmission (Dore et al., 1999), some sub-groups of users are still at high risk of
becoming infected with HCV, particularly in prisons where prevalence is very high
(Dolan, 2000) and young people who are new to injecting (Williams, 2000).
The principal strategy for preventing HCV transmission from injecting drug use,
is to avoid re-using any injecting equipment (MacDonald & Wodak, 1999). Such
initiatives include the provision of needle and syringe exchange programs, peer based
education for injecting drug user groups on safer injecting practices, methadone
maintenance programs and education and prevention activities in prisons (Williams,
2000; Lowe & Cotton, 1999). However, despite these preventative efforts many people
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still choose to share injecting equipment due to various factors such as lack of access,
lack of knowledge or as part of an intimate, trusting relationship, consequently
increasing the chances of transmitting or contracting hepatitis C (Williams, 2000).
2.3 .2. Blood transfusions and blood products.
Since the screening of blood supplies in 1990, transmission of hepatitis C
through blood transfusions and blood products is extremely low, with approximately
one case per 250,000 donations (Dore et al., 1999; HCCWA, 1 998). Furthermore, due
to the recent introduction of more sensitive nucleic acid testing for hepatitis C since
June 2000, the risk of transmission from blood transfusions in Australia is virtually
eliminated (DHAC, 2000). For people who received blood transfusions or blood
products prior to 1 990, a moderate risk of contracting hepatitis C exists {HCCWA,
1998). This risk is the highest for haemophiliac patients or those who had multiple
transfusions prior to the screening of blood supplies (Dore et al., 1999).
2.3.3. Unsafe tattooing and body piercing.
Tattooing and other skin penetration procedures such as body piercing have also
been implicated as risk factors for the transmission of hepatitis C (Thompson,
Hemberger, Wale & Crofts, 1996; HCCWA, 1998; MacDonald & Wodak, 1999). It has
been suggested that such procedures pose a medium to high risk, particularly if not
carried out under sterile conditions (HCCWA, 1998; Dore et al., 1 999). There is the
potential for transmission to occur from client to client if tattooing needles and piercing
equipment are not sterilised between clients, or if tattoo ink tubs are shared
(Communicable Disease Control Branch (CBCD), 1999). Transmission can also occur
from operator to client, or client to operator if the body artist does not use standard
safety precautions for skin penetration procedures, such as wearing disposable gloves
(CDCB, 1 999).
2.3.4. Needlestick injuries/ occupational transmission.
Despite common belief, often due to media reports, the risk of transmitting the
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hepatitis C virus through needle stick injuries is relatively low (Dore et al., 1 999).
However, given the blood borne nature of transmission, healthcare workers are
potentially at risk of exposure to hepatitis C (SCSI, 1 998). It is believed that the
estimated risk of transmission following a needle stick injury involving HCV positive
blood is about 4% (HCCWA, 1 998). To put this figure into perspective, the risk of
hepatitis B and HIV transmission following exposure to positive blood, is 30% and
0.4% respectively (HCCWA, 1 998).
There has been limited research on occupationally acquired HCV infection in
Australia, however one project by the National Centre in HIV Epidemiology and
Clinical Research (NCHECR) monitors occupational exposure to HCV among
healthcare workers in Australian hospitals (MacDonald, Correll & Dore, 2000). Since
project monitoring began in 1 995, no workers were reported as acquiring hepatitis C
following exposure to the virus in the workplace. However, the authors noted that
testing rates at three months after exposure were low and it is possible that there may
have been workers who were infected and chose not to report this information
(MacDonald, Correll & Dore, 2000). Despite the small amount of research conducted
in this area, the risk of HCV transmission through occupational exposure or needlestick
injuries appears to be low. Nevertheless, there is a risk and healthcare workers should
be encouraged to adhere to standard safety precautions when conducting exposure
prone procedures.
2.3.5. Other modes of transmission.
Hepatitis C transmission through routes other than those already discussed is
generally thought to be uncommon, however any behaviour that involves blood-to
blood contact is potentially a risk for the transmission of the virus (Dore et al., 1 999).
Household transmission of hepatitis C appears to be extremely rare, although the
possibility of blood to blood contact exists if toothbrushes, razors or similar items are
shared, however there is no conclusive evidence to support this (MacDonald & Wodak,

Living With Hepatitis C 1 1

1 999).
It is generally recognised that hepatitis C is not a sexually transmitted virus and
studies have concluded that sexual practices not involving blood, are considered to be
very low risk (Dore, 2000b). Contrary evidence suggests that approximately 1 0% of
people with hepatitis C in the United States report acquiring the virus through sexual
exposure (SCSI, 1 998). It is possible however, that for many people it is more
favourable to report sexual transmission, rather than admit a history of injecting drug
use. Despite inconclusive evidence about whether or not hepatitis C is transmitted
sexually, general agreement is that:
Sexual transmission is of very low prevalence. A very low
proportion of new cases. There is argument about whether it is
very, very low or just very low, but it certainly would not be more
than one percent of all new transmissions (Wodak evidence, cited
in SCSI, 1 998, p. 91).
The risk associated with mother to child transmission (vertical transmission) is
unclear, with figures estimating that less than 5% of babies will acquire the virus from a
mother with hepatitis C (HCCWA, 1 998). It is thought that high levels of virus in the
mother at the time of pregnancy is the strongest risk factor for vertical transmission of
hepatitis C (MacDonald & Wodak, 1 999), however maternal co-infection with HIV has
also been associated with an increased risk of transmission (Papaevangelou et al.,
1 998).
2.4 Treatment
Currently, there is no vaccine or effective cure for hepatitis C infection, however
there are treatments and therapies available that seek to reduce viral replication and
inflammation of the liver (Sievert & Korevaar, 1 999). The goal of these treatments is to
produce a sustained response (SR), which is defined by normal liver function tests and
undetectable levels of the virus at either six or twelve months after the completion of
treatment (Sievart & Korevaar, 1999). At present there are two types of anti-viral
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treatments in Australia, interferon monotherapy and interferon combined with ribaviran
(combination therapy) (Sievart, 2000). Studies suggest a significant advantage of
combination therapy over interferon therapy alone, however both available treatments
have limited success rates (between 1 9% and 64%) (Poynard et al., 1 998). More
recently, it has been suggested that the use of newer, longer acting ('pegylated')
interferons may further increase sustained response rates, although trials are still being
conducted to determine their effectiveness (Sievart, 2000).
Anti-viral treatment provides many people with a sense of hope that the virus
may be eliminated, however it brings its own set of adverse physical and psychological
side effects, which in turn can impact enormously on the life of the individual (Burrows
& Bassett, 1 996; Sievart & Korevaar, 1 999). Reported side effects include nausea, flu
like symptoms, weight loss, diarrhoea, anaemia, anxiety, depression and in some cases
suicidal ideation (Sievart & Korevaar, 1 999). The debilitating effect of these symptoms
can often cause people to cease treatment and thus lead to feelings of failure and
hopelessness (Burrows & Bassett, 1996). In addition, it has been noted previously that
treatment is only successful in a limited number of cases, so there are significant
numbers of people who complete the course of treatment and either do not respond or
relapse after a few months (Sievart & Korevaar, 1999). This again can lead to feelings
of hopelessness, disappointment and anger in those who 'fail' treatment, as it is often
viewed as the last chance or the last hope for eliminating the virus (Burrows & Bassett,
1 996).
2.5 He.patitis C and HIV: A Comparison
The main characteristics of hepatitis C, including the prevalence, natural history,
transmission and treatment have been discussed, thus providing a general overview of
the nature of the virus. At this point it would be useful to summarise the features of
hepatitis C by making a comparison with HIV, a virus of which the general community
is relatively more aware (see Table 1 ) (NCHECR, 1 999).
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While some strong parallels can be drawn between the two viruses, there are
also some striking differences (Orr & Leeder, 1998). For example, hepatitis C and HIV
are both infectious blood-borne viruses, both went unrecognised for a period of time
and both primarily affect populations who are socially marginalised (Orr & Leeder,
1 998). However, hepatitis C was identified much later on the epidemic curve than HIV,
and therefore a much larger pool of infection already existed within the population (Orr
& Leeder, 1998). When compared to HIV, hepatitis C is a much more infectious and
robust virus and therefore is more readily transmitted through the sharing of drug
injecting equipment and needle stick injuries (Wodak & Crofts, 1996). Serious health
complications occur more quickly in those with HIV in comparison to the slow acting
nature of hepatitis C (Wodak & Crofts, 1996).

Table 1
Summary of HCV and HIV: A Comparison
HCV
Feature
Start of epidemic
early 1970's
200, 000
Prevalence
1 1 , 000
New infuctions/ year
1%
Proportion of popu1ation
infucted
blood to blood contact
Mode oftransmission
Highest risk behavilur

irtjecting drug use

HIV
early 1 980's
18, 000
500
0. 1 %
blood to blood contact
sexual transmission
male hmmsexual contact

It is clear that hepatitis C has become a widespread virus of epidemic
proportions. Given the probability that a massive pool of unknown infection exists in
the population, it seems certain that a significantly high number of people will be living
with chronic liver disease, and the associated consequences, in the very near future (Orr
& Leeder, 1 998). Attention needs to be given to the seriousness of this public health
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issue, and in doing so the level of awareness and understanding of what hepatitis C
means for the person needs to be increased.
3. Impacts of Hepatitis C
Given that hepatitis C is a chronic, long term illness, the importance of research
examining the personal and social impacts of hepatitis C infection and subsequent
quality of life, has only recently been acknowledged (ANCARD, 1999). As a result, the
amount of research focusing on the consequences of hepatitis C infection and quality of
life has increased, however it is relatively limited and the impacts are still not clearly
understood.
Quality oflife (QOL) is generally defined as an individual's overall satisfaction
with life and sense of well-being (Koff, 1999). Although quality oflife is a concept that
everyone intuitively understands, it is difficult to define and measure, due to the
subjective nature of the term (Swain, 2000). Therefore, hepatitis C research has mainly
focused on the more narrowly and specifically defined concept of health related quality
oflife (HRQOL), which aims to estimate the impact of chronic illness on various
domains, including physical functioning, somatic sensation, psychological status, social
interactions and sense of well being (Koff, 1999). Research in this area has utilised
both quantitative, and more recently qualitative methodologies, to identify the various
personal and social impacts of hepatitis C and how these affect changes in HRQOL.
The relevant literature will be discussed in more detail.
3.1 . Quantitative Assessment of Health Related Quality of Life (HROOL)
To date, the measurement of HRQOL among people with hepatitis C, has most
frequently been undertaken through the use of multi-item questionnaires and self report
survey instruments (Swain, 2000). Typically these measures are designed to assess an
individual's perception of illness and quantify the impact on their life (Swain, 2000).
The main instruments used to measure HRQOL among hepatitis C populations, are
generic questionnaires such as the Short-Form 36 (SF-36) (Ware & Sherbourne, 1992)
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and hepatitis C specific assessment tools such as the Hepatitis Quality of Life
Questionnaire (HQLQ) (Bayliss, Gandek, Bungay, Sugano, Hsu & Ware, 1 998) and the
Chronic Liver Disease Questionnaire (CLDQ) (Younossi, Guyatt, Kiwi, Boparai &
King, 1 999).
3.1 . 1 . Short-form 36 (SF-36).
Perhaps the most common measurement tool to be used in hepatitis C research,
is the Short-Form 36 (SF-36), a generic questionnaire designed to assess health related
quality of life (Ware & Sherboume, 1 992). The SF-36 is a multi-item scale which
measures eight health related concepts, namely physical function; social functioning;
role limitations due to physical problems; bodily pain; mental health; role limitations
due to emotional problems; vitality and general health perceptions (Ware & Sherboume,
1 992). The SF-36 is self-administered, is rapid and easy to complete and has shown to
have acceptable reliability and validity among various populations (Koff, 1 999).
Studies utilising the SF-36 among people with chronic hepatitis C, are only
relatively recent and generally they have demonstrated a significant decline in all eight
sub-scales of the SF-36 for those infected with the virus, when compared to healthy
controls (Bonkovsky & Woolley, 1 999; Carithers, Sugano & Bayliss, 1 996; Foster,
Goldin & Thomas, 1 998). Although the results from these studies indicated that people
living with HCV had lower quality oflife across all domains, the greatest reductions
appeared to be on the physical sub-scales as opposed to the categories measuring mental
and emotional health, suggesting that the greatest impact of HCV was of a physical
nature (Foster et al., 1 998; Bonkovsky & Woolley, 1 999).
Foster et al. (1 998) also compared quality of life in people with chronic HCV,
with those who were infected with chronic hepatitis B. Interestingly, HCV participants
scored lower on all domains of the SF-36, however scores were only significantly
poorer in areas of social functioning, physical role limitations and vitality (energy and
fatigue) (Foster et al., 1 998). These results suggest that the reduction in quality of life
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among HCV participants could not be attributed to the degree of liver inflammation,
and therefore the nature of impairment associated with HCV may be qualitatively
different to the symptoms associated with HBV (Foster et al., 1998).
Bonkovsky and Woolley ( 1999) also evaluated the effect of chronic hepatitis C
on HRQOL by using the SF-36. The main aim of this study was to determine whether
treatment of 642 participants with interferon therapy, subsequently improves HRQOL.
Similar results to Foster et al. (1998) were reported, with baseline measures of HRQOL
being significantly lower across all domains of the SF-36 for HCV patients, when
compared to healthy controls (Bonkovsky & Woolley, -1999). In addition, when
compared to non-responders, it was found that those who had a sustained response to
treatment, showed a significant improvement in HRQOL within five of the eight sub
scales, six months after treatment had ceased (Bonkovsky & Woolley, 1999). One
significant flaw in this study was that participants were not blind to their responses
during the treatment phase. In other words, participants knew whether or not they were
responding to interferon and this awareness may have influenced their perceived health
status (Swain, 2000).
There are also some general limitations of studies that have used the SF-36 to
measure HRQOL among people with hepatitis C and therefore results should be
interpreted with caution. Most studies compared HCV participants with 'healthy' rather
than 'normal' control populations, therefore the differences in perceived quality of life
may appear to be more pronounced than what is actually the case (Swain, 2000).
Another big problem with the SF-36 is the fact that it is a generic assessment tool,
which is useful for direct comparisons ofHRQOL between people with hepatitis C and
other populations, however they are based on the assumption that chronic illnesses
impact on people in similar ways (Swain, 2000; Garrett & Conrad, 2001). In addition,
the use of generic questionnaires gives rise to the possibility that information regarding
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disease-specific impacts and changes in functioning can be lost (Borgaonkar & Irvine,
2000).
3.1.2. Hepatitis C specific measures of HROOL
The use of generic instruments to measure HRQOL and the awareness of their
associated limitations, has led to the recent development of assessment tools that are
specific to hepatitis C. One such attempt has been by Bayliss et al. (1998) who
developed the Hepatitis Quality of Life Questionnaire (HQLQ), a 69-item questionnaire
designed to measure both generic functioning and disease-specific health outcomes.
The HQLQ included all eight scales from the SF-36, in addition to measures of nine
other generic and hepatitis C specific health concepts. Bayliss et al. tested the
questionnaire on people with chronic hepatitis C who were receiving interferon
treatment and found that participants scored lower on the generic scales than patients
with other chronic illnesses, and worse than a healthy general population. Although the
disease-specific scale scores were also found to be lower for hepatitis C, the HQLQ
appeared to have no significant advantage over using the SF-36 alone (Bayliss et al.,
1998). Furthermore, so far the HQLQ has only been used with participants who are
receiving interferon treatment and the effectiveness of this questionnaire on untreated
hepatitis C populations, is yet to be determined.
Another disease specific instrument called the Chronic Liver Disease
Questionnaire (CLDQ) has also been recently developed and is designed to measure
HRQOL in people with chronic liver disease, including hepatitis C (Younossi et al.,
1999). Literature, expert opinion and patient focus groups, were used to generate the 29
item questionnaire, which focuses on six domains that impact on quality of life for
people with chronic liver disease: fatigue, activity, emotional function, abdominal
symptoms, systemic symptoms and worry (Younossi et al., 1999). The CLDQ has been
shown to have a number of advantages including short and easy administration,
moderate test-retest reliability after six months and appears to discriminate between
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people with varying degrees of liver damage (Younossi et al., 1 999). The CLDQ is still
in the initial stages of being utilised to assess HRQOL in people with hepatitis C and
more research is needed to evaluate it's efficacy, however the CLDQ exhibits a number
of potential strengths which may allow future widespread application among this
population.
3 . 1 .3. General limitations.
Both generic and disease specific measures of HRQOL are in the beginning
stages of development, particularly with respect to hepatitis C. Nevertheless, results
from studies conducted so far, have suggested that people living with hepatitis C
experience a significant decline in quality oflife, with the greatest deficits appearing to
be physical in nature. It has been argued however, that using questionnaire type tools to
assess HRQOL does not directly address the mechanisms underlying the apparent
decline (Koff, 1 999). In other words, this method of assessment demonstrates that there
are impacts of hepatitis C that have a detrimental affect on quality oflife, but they do
not specifically explain what these impacts are or why they affect quality of life (Koff,
1 999). Despite this limitation, HRQOL assessment tools have a very important place in
hepatitis C related research and can be used to evaluate treatment efficacy and enhance
knowledge of the virus (Borgaonkar & Irvine, 2000).
3.2. Qualitative Research: Personal and Social Impacts
Recent interest in identifying and understanding the potential impacts of
hepatitis C, has led many researchers to adopt a qualitative approach to explore these
impacts in more detail (Garrett & Conrad, 200 1 ; Burrows & Bassett, 1 996). It is argued
that qualitative inquiry is better suited to develop an understanding of personal
meaning, while revealing important insights into human experiences (Miles &
Huberman, 1994). Research in this area has attempted to explore the impacts of
hepatitis C by conducting in-depth interviews or focus groups, in order to understand
the personal experiences of people living with the virus (Crossen, Brunton, Plumridge
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& Jang, 1 999; Burrows & Bassett, 1996; Garrett & Conrad, 2001). Unfortunately, the
amount of formal research in this area is relatively scarce and much of the current
knowledge regarding the personal and social impacts of hepatitis C, has come from
personal submissions (SCSI, 1 998) or anecdotal evidence provided from case notes or
workers in the field (Lowe & Cotton, 1 999). However, the research suggests that a
positive diagnosis of hepatitis C results in a range of physical, psychological and social
impacts, which will be discussed further.
3.2.1 . Receiving the diagnosis
For many people, receiving the news that they have contracted hepatitis C, is a
shocking and traumatic experience (Burrows & Bassett, 1996). In most cases, it
appears that people are generally informed by their doctor, however some people have
reported being told over the phone or via letters from blood banks (Crossen et al., 1 999;
Burrows & Bassett, 1996). While a small minority of participants in Burrows and
Basset's study were satisfied with the amount of information and support they received
at the time of diagnosis, there have been a large number people who were unhappy with
the way they were informed (Crossen, et al. 1 999; Burrows & Bassett, 1 996). Pre-test
and post test counselling is designed to reduce the impact of a positive diagnosis by
providing sufficient information about possible outcomes, educating the person on the
risk of transmission and ensuring that there is adequate support available (McCoy,
Watson & Kosky, 1 999). Unfortunately, studies have indicated that the number of
people who actually receive this counselling are limited (Crossen et al., 1 999; Burrows
& Bassett, 1 996), and many people experienced increased stress and anxiety due to the
lack of information and uncertainty surrounding the outcomes of hepatitis C infection
(Garrett & Conrad, 2001; Crossen et al., 1999; Lowe & Cotton, 1 999).
3.2.2. Physical symptoms.
By far the most commonly reported physical symptom of chronic hepatitis C has
been fatigue, ranging from minimal or episodic lethargy, to overwhelming and
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debilitating exhaustion (Burrows & Bassett, 1 996; Garrett & Conrad, 2001 ). One of the
reported difficulties associated with fatigue is the unpredictability of onset, which for
many people means they can not plan for more than a day at a time (Glacken, Kernohan
& Coates, 2001 ). The experience of fatigue for many people with hepatitis C has also
been reported to contribute to a reduction in social mobility and thus can influence a
sense ofisolation (Glacken et al., 2001 ).
Other common physical symptoms include nausea, headaches and pain in the
right side of the abdomen, however muscle aches, intolerance to fatty foods, skin rashes
and weight loss have also been reported (SCSI, 1 998; Burrows & Bassett, 1 996). It has
been noted previously that people on interferon or combination treatment, may also
experience adverse physical symptoms (see section 2.4). It is important to note that
participants in these studies generally did not experience symptoms all of the time and
they could be more or less severe on different days (Burrows & Bassett, 1 996).
Garrett and Conrad (2001 ) found that the physical impacts of hepatitis C were
often surrounded by feelings of uncertainty, in particular the unpredictability associated
with the onset of symptoms and what that meant in regards to the progression of the
virus. White and Lubkin (1998) suggest that the uncertainty and unpredictable nature
associated with many chronic illnesses can have enormous implications for the
individual, often resulting in a number of psychological effects, which will be discussed
further in the next section.
3.2.3. Psychological and emotional impacts.
Studies suggest that a positive diagnosis of hepatitis C may also create
significant psychological and emotional impacts (SCSI, 1 998). As noted in the previous
section, it appears that in many cases the presence of physical symptoms can often lead
to psychological effects such as depression, mood swings, anxiety, stress and decreased
self esteem (Loveday et al., 1 999). Depression seems to be the most commonly cited
psychological effect (Burrows & Bassett, 1 996), and appears to be more significant in
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those who have been diagnosed for more than five years, or for those who are over fifty
years of age (Kraus, Schafer, Csef, Scheurlen & Faller, 2000). This suggests that the
amount of time that a person knows they have hepatitis C, could possibly influence their
emotional state (Kraus et al, 2000).
Other psychological impacts of hepatitis C such as short term memory loss
(Garrett & Conrad, 2001 ), irritability and 'shattered dreams' have also been reported
(Burrows and Bassett, 1 996). An interesting exploratory study by Glacken et al.(2001 ),
found that the majority of participants experienced an altered self concept and decreased
self esteem, following a positive diagnosis. Many participants considered themselves as
'contaminated', 'dirty' and 'unclean', mixed in with feelings of anger, bitterness, fear,
frustration and a sense of hopelessness (Glacken et al., 2001 ). It has also been reported
that the ambiguous nature ofHCV can lead to a reduced sense of control and
uncertainty about the future (Garrett & Conrad, 2001).
3.2.4. Coping and support
A cross sectional study by Kraus et al. (2000), explored coping styles among
people with chronic hepatitis C. These authors found that the most common coping
mechanism was problem solving behaviour, however distraction and self re-evaluation
were also frequently employed (Kraus et al., 2000). Other reported methods of coping
with physical symptoms such as fatigue, have been diet and exercise (Garrett & Conrad,
200 1 ), and stress management techniques such as meditation, yoga and counselling
(Stadden, Hickey, Dunn & Beard, 1998).
Social support has shown to be an important factor in reducing the negative
impacts of a positive diagnosis (Glacken et al., 2001). Many participants in New
Zealand based research reported that friends and family provided the greatest amount of
support, while others mentioned their general practitioner and hepatitis C support
groups (Crossen et al., 1999).
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3.2.5. Effect on family and relationships.
R eports of personal experiences have suggested that h epatitis C can have a
negative impact on family and relationships (Burrows & Bassett, 1996; SCSI, 1998).
Fear of transmission to partners and children appears to be a common example, even
though the risk is very low (Loveday et al., 1999). This can lead to a reduction in the
amount of interaction with partners and children. Examples given by women have
included being cut off from their families because of h epatitis C due to fear and
confusion concerning the risks of transmission (Gifford & O'Brien, 2001 ). Some
examples of comments given by women include:
I used to be able to hug them (my family) and kiss them and now I'm
not allowed to touch them or anything (Gifford & O'Brien, p l2.)
I planned to have children in the next few years and that's really scary
because it's not something I want to pass on to my kids. Do I have a
right to marry this man and have his children if I'm going to put my
kids at risk? (Gifford & O 'Brien, p l 2.)
Other impacts on family are influenced by the ability to have the physical
energy to look after, raise and interact with children, which for many people is greatly
reduced (SCSI, 1998). Some people have reported negative attitudes, behaviour or
rejection from partners and friends, mainly due to fear and ignorance, while others have
reported positive support and the strengthening of relationships (Burrows and Bassett,
1 996).
3.2.6. Effects on work.
Many people with hepatitis C have found that the virus can have a devastating
effect on the ability to continue their jobs and careers, due to increasing fatigue or stress
(Burrows & Bassett, 1996). In a study exploring the experiences of women, it was
found that the difficulty in gaining and maintaining employment led to negative
financial implications and economic hardship (Gifford & O'Brien, 2001). Other
reported impacts have included having to leave current jobs, engaging in a total career
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change or being sacked because of a reduced ability to keep up (Burrows & Bassett,
1996). Another serious impact of being diagnosed with hepatitis C, is the experience of
discrimination, stigma and isolation in the work place (Lowe & Cotton, 1999), and
exploration of this issue will be discussed further in section 3.2.8.
3.2.7. Disclosure.
While there is no legal obligation to disclose hepatitis C status, it appears to
remain a big issue and can have significant impacts for many people (HCCWA, 1998).
Disclosure was a major issue for the women in Gifford and O'Brien's (2001) recent
study. The dilemma facing these women, and indeed many people with hepatitis C, is
the choice between telling someone their status in order to gain support or warn them of
potential risk, and the real fear of being rejected or being subjected to stigma and
discrimination (Gifford & O'Brien, 2001; Burrows & Bassett, 1996). Many people
have experienced adverse consequences within family, friends, relationships and work
and personal anecdotes include:
I need some information to send to my brother who won't let me
touch his kids. Telling my family was the biggest mistake I ever
made (Burrows & Bassett, p.25).
I've lost a lot of people - ifl make coffee at my house people won't
drink it and I haven't seen some of them since telling them (Burrows
& Bassett, p.26).
Other people have reported that although disclosure can be difficult, it can be a
positive experience:
I'm fortunate because a friend of mine is also positive. She's very
supportive and helpful...telling people is part of the process of
accepting it (Burrows & Bassett, p.25).
Whether the experience of disclosure is positive or negative, the decision to do
so often creates a lot of stress and anxiety and the impact can be quite significant
(Burrows & Bassett, 1996). For example, for some people, the fear of potential
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rejection is so great that they choose not to involve themselves in relationships (Garrett
& Conrad, 2001).
3.2.8. Discrimination and stigma
There is a growing amount of literature that powerfully reveals the extent to
which people living with HCV experience stigmatisation and discrimination. Stigma is
a socially constructed concept associated with shame and discredit, whereas
discrimination is the differing treatment or action which is based on stigma (Ward,
Colebome & Fort, 2000). It is suggested that characteristics which contribute to the
stigmatisation of many chronic diseases include an unclear cause or progression,
ineffective treatment, transmissible nature and association with an already marginalised
group (Saylor & Yoder, 1998). All of these factors are characteristic of hepatitis C and
therefore various degrees ofHCV related stigma and discrimination are present in the
community, largely as a result of negative attitudes towards injecting drug users (Ward
et al., 2000; SCSI, 1998; Burrows & Bassett, 1996).
Research by Crofts, Louie and Loff ( 1997) reported that the range of settings in
which hepatitis C discrimination occurred was extensive. The majority of
discrimination incidents were reported to have occurred in health care settings (56%),
while others had occurred in domestic settings (22%), occupational settings (20%) and
recreational settings (5%). A wide range of discriminatory incidents were also reported
by participants in Burrows and Bassett's (1996) study. A large number of people noted
that the negative attitudes they experienced, were influenced by the assumption that
people with hepatitis C are injecting drug users, and a high level of discrimination was
reported as coming from health care workers (Burrows & Bassett, 1996).
When someone gets cancer from smoking, they're treated respectfully
in hospital. Whereas with hepatitis C it's 'You knew it (injecting
drug use) could be dangerous. You deserve what you get'. They
want to get you out as quickly as possible. (Burrows & Bassett, p.33).
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Dealing with stigma and discrimination is often an everyday reality for people
living with hepatitis C and can have a significant impact not only on the life of the
individual, but also on the lives of their family and friends (Ward, Colebome & Fort,
2000). Reported impacts of stigma have included devalued sense of self, diminished
self esteem (Gifford & O'Brien, 2001), secondary health care, ending of relationships
and termination of employment (Crofts, Louie & Loff, 1 997).
These experiences appear to be a common link between many studies exploring
the impacts of hepatitis C and some have suggested that it has become a secondary and
underlying epidemic that people living with the virus have to deal with (SCSI, 1 998).
The recent acknowledgement of the widespread extent of hepatitis C related
discrimination, has led to the National Hepatitis C Strategy stating the reduction of
discrimination, particularly in healthcare settings, as a national priority (DHAC, 2000).
It is clear that more research is needed to further understand the extent and nature of

hepatitis C related stigma and discrimination, in order to reduce the impact of this
significant issue.
3.3. Development of a Socio-Cultural Perspective
Although research exploring the impacts of hepatitis C is relatively new,
qualitative studies have begun to provide a clearer picture of how these impacts affect
quality oflife. However some researchers have argued that hepatitis C is primarily
viewed as a medical condition, with emphasis on the impact of physical symptoms
(Hepworth & Krug, 1999). It has also been suggested that the non-physical effects of
hepatitis C are typically represented as being located within the individual and as
individual problems (Hepworth & Krug, 1999). A recent change in thinking has led
some researchers to view hepatitis C as not only a medical, physical or individual
problem, but as a virus whose impacts are influenced by social, cultural and political
factors (Glacken et al., 2000; Hepworth & Krug, 1 999). These researchers argue that a
positive hepatitis C diagnosis accompanies a range of impacts to which they have to
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adapt, and these changes are not only derived from psychological reactions, but also
from the social and cultural relationships in which the individual is embedded
(Hepworth & Krug, 1 999).
This viewpoint is consistent with Bronfenbrenner's (1 979) systems theory,
which argues that an individual exists in, and is influenced by a series of interconnected
systems, within their environment. Bronfenbrenner's theory has long been associated
with human development, however a similar framework could be applied to the
experience of chronic illnesses (Strauss et al., 1 984). For example, some aspects of
hepatitis C such as symptoms of fatigue and depression (Burrows & Bassett, 1 996;
SCSI, 1 998), affect the person at an individual level which Bronfenbrenner describes as
the microsystem. Impacts at a social level, including negative impacts on work, family
and relationships (Burrows & Bassett, 1 996; SCSI, 1 998) and inadequate pre-test and
post-test counselling (Crossen et al., 1 999) could be described as the mesosystem
(Bronfenbrenner, 1 979). Negative community attitudes and social policy are aspects of
an even broader environmental context, which Bronfenbrenner calls the exosystem.
A systems or socio-cultural approach also suggests that impacts at one particular
level of the system will have implications for other levels of the system
(Bronfenbrenner, 1 979). For example, in relation to hepatitis C, the fear of
discrimination may have an effect on the working environment. While some current
research has hinted at the potential applicability of an ecological approach to
understanding the personal and social impacts of hepatitis C, no such study has
attempted to apply a systems framework to understand these impacts.
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4. Overview and Future Directions
It is clear that hepatitis C has become a widespread virus of epidemic
proportions within the Australian community. Given the current prevalence and
incidence rates, it is probable that a significantly high number of people will be living
with chronic liver disease, and the associated consequences, in the very near future (Orr
& Leeder, 1 998). There is currently no vaccine, or cure, and treatment is not successful
in many cases, so HCV is for most people a life long condition with long term effects.
As a result, attention.needs to be given to the seriousness of this public health issue, and
the level of awareness and understanding surrounding the impacts of hepatitis C needs
to be increased.
In comparison to the amount of research on the epidemiology, prevention and
treatment of hepatitis C, relatively few studies have documented the extent to which a
positive diagnosis impacts on various aspects of a person's life (Garrett & Conrad,
200 1 ; Burrows & Bassett, 1 996; Crofts, Louie & Loff, 1997). Quantitative studies have
utilised both generic and hepatitis specific assessment tools to measure the concept of
health related quality of life. Generally results have indicated that HCV can lead to a
significant decline across all areas, particularly within the physical domain. However,
quantitative quality of life research is limited in the amount of detail that can be
provided about the nature of the impacts and how the person is affected. The further
development of hepatitis specific assessment tools and the increased use among people
with HCV, is needed to improve the efficacy of these instruments.
In reviewing the qualitative literature, a more detailed picture of personal
experiences has emerged. There appears to be a wide range of impacts for people living
with hepatitis C, ranging from physical symptoms such as fatigue, to the experience of
stigma and discrimination. The findings from these studies not only indicate significant
personal impacts for the individual, but social impacts as well, however more research
needs to be conducted. In order to provide adequate care and support for people living
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with hepatitis C, it has been recommended that further knowledge is needed in order to
understand the impacts of a hepatitis C diagnosis, and how they affect quality of life
(DHAC, 2000). Research is needed to explore how hepatitis C impacts on the physical,
psychological, social and cultural environments of an individual, and how these
different spheres can impact on the experience of hepatitis C.
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Abstract
Hepatitis C (HCV) has become one of the most widespread blood borne viruses
in many Westernised countries and a positive diagnosis can significantly impact on
various aspects of a person's life. Using a systems perspective, the present study aimed
to explore the physical, psychological and social impacts of HCV on 12 participants
who were living with the virus in Perth, Western Australia. Qualitative semi-structured
interviews were conducted, and content analysis revealed six main themes:.finding out;
being infectious; disclosure; stigma; symptoms; dealing with it. A comprehensive

systems framework is used to understand and explain the impacts of HCV and how
these affected participants' quality of life. The findings have implications for providers
of health care, helping services, the general community and makers of government
policy.

Keywords: Hepatitis C, qualitative research, impacts, systems framework,
discrimination
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The physical, psychological and social impacts of hepatitis C and the effect on quality
of life
In the past decade, hepatitis C (HCV) has become one of the most widespread
blood-borne viruses, creating a major public health issue in Australia (Department of
Health and Aged Care (DHAC), 2000). It is estimated that over 200,000 people have
been infected with hepatitis C and up to 1 1 ,000 new infections are reported each year
(DHAC, 2000). Hepatitis C affects the liver and is transmitted via blood to blood
contact, with the large majority of infections resulting from the sharing of injecting drug
equipment (Hepatitis C Council of WA (HCCWA), 1 998). Other modes of
transmission include unsafe tattooing, body piercing or receiving blood transfusions
prior to the screening of supplies in 1 990 (HCCWA, 1 998). Approximately 80-85% of
people who contract the hepatitis C virus become chronically infected and may
experience various ranges of liver damage, possibly leading to cirrhosis, liver cancer or
liver failure (Dore, 2000; Lin, Barker & Batey, 1 999). As there is no vaccine available
for hepatitis C and treatment is not successful in a significant number of cases (Standing
Committee on Social Issues (SCSI), 1 998; Sievert & Korevaar, 1 999), for many people
hepatitis C is a life long condition with long-term effects (Lowe & Cotton, 1 999; SCSI,
1 998; Loveday, Deakin & Neophyton, 1 999).
There has been a large amount of research on the epidemiology (Dolan, 2000;
Dore, 2000), prevention (Wodak & Crofts, 1 996) and treatment (Sievert & Korevaar,
1 999) of hepatitis C, however the importance of examining the personal and social
impacts ofHCV infection and subsequent effects on quality of life, has only recently
been acknowledged (ANCARD, 1999, Garrett & Conrad, 200 1 ; Burrows & Bassett,
1 996; Crofts, Louie & Loff, 1 997). Quantitative research has utilised both generic and
disease specific questionnaires to measure health related quality of life (HRQOL)
among people living with hepatitis C. Generally it has been suggested that the hepatitis
C virus is associated with a significant decline in quality of life, with the greatest
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deficits appearing to be physical in nature (Bonkovsky & Woolley, 1 999; Bayliss et al,
1998; Foster, Goldin & Thomas, 1998).
While it is widely acknowledged that physical symptoms undeniably affect
quality of life, a number of qualitative studies have suggested that other issues such as
disclosure, family and relationship impacts also appear to be serious concerns for
people living with hepatitis C (Burrows & Bassett, 1 996; Garrett & Conrad, 200 1 ;
Crofts, Louie & Loff, 1997). In addition, there has been a growing body of literature
which indicates that discrimination and stigmatisation are frequently experienced by
people with the virus, largely as a result of negative attitudes towards injecting drug
users (Ward, Colebome & Fort, 2000; SCSI, 1998; Burrows & Bassett, 1996). Crofts,
Louie and Loff (1 997) interviewed a number of people with HCV about their
experiences of discrimination and found that the range of settings in which hepatitis C
discrimination occurred was extensive, with a large proportion of incidents taking place
in health care settings.
Hepatitis C has been commonly viewed in the literature as a medical or physical
problem which primarily impacts on the individual. However, a recent change in
thinking has led some researchers to view the experiences of hepatitis C in a wider
context, with impacts being influenced by social, cultural and political factors (Glacken,
Kemohan & Coates, 2001; Hepworth & Krug, 1999). These researchers argue that a
positive hepatitis C diagnosis accompanies a range of impacts to which people have to
adapt, and these changes are not only derived from the psychological reactions of
having a chronic illness, but also from the social and cultural relationships in which the
individual is embedded (Hepworth & Krug, 1999).
This viewpoint is consistent with Bronfenbrenner's (1 979) systems theory,
which argues that an individual exists in, and is influenced by a series of
interconnecting systems, within their environment. Bronfenbrenner's theory has long
been associated with human development, however a similar framework could be
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applied to the experience of chronic illnesses (Strauss et al., 1 984). For example, some
aspects of hepatitis C such as symptoms of fatigue and depression (Burrows & Bassett,
1 996; SCSI, 1 998), affect the person at an individual level, which Bronfenbrenner
describes as the microsystem. Impacts at a social level, including negative impacts on
work, family and relationships (Burrows & Bassett, 1 996; SCSI, 1 998) and inadequate
pre-test and post-test counselling (Crossen et al., 1 999) could be described as the
mesosystem (Bronfenbrenner, 1979). Negative community attitudes and social policy
are aspects of an even broader environmental context that Bronfenbrenner calls the
exosystem.
A systems or socio-cultural approach also suggests that changes at an individual,
social or cultural level, will ultimately have implications for other levels of the system
(Bronfenbrenner, 1 979). For example, in relation to hepatitis C, physical impacts such
as fatigue (individual) may have an effect on the working environment (social). While
some current research has hinted at the potential applicability of an ecological approach
to understanding the personal and social impacts of hepatitis C, no study has attempted
to apply a systems framework to understand these impacts.
Furthermore, in order to provide adequate care and support for people living
with HCV, it has been recommended that further knowledge is needed to understand the
impacts of a positive diagnosis (DHAC, 2000). Using a systems perspective, this study
sought to examine the experiences of people living with HCV and explores the physical,
psychological and social impacts of the virus. In addition, the present study aimed to
develop a framework in which the impacts ofHCV could be clearly understood, and
how these aspects affect quality of life for people living with the virus.
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Method
Design
A qualitative approach, using semi-structured interviews, was adopted for the
present study in order to understand the experiences of people who were living with
hepatitis C. It is argued that qualitative inquiry is better suited to develop an
understanding of meaning while allowing a free and open forum to expose regularities
and reveal insights to human experiences (Miles & Huberman, 1994). While
quantitative research focusing on hepatitis C has indicated that people living with the
virus experience a reduction in quality of life, it does not explain what the specific
impacts are or how they affect quality of life (Koff, 1999). Qualitative research is
valuable as it allows an in depth exploration of the personal and social impacts of
hepatitis C and can reveal details that quantitative inquiry may miss.
Participants
The aim of this study was to explore people's experiences of hepatitis C,
therefore it was essential that participants had the required knowledge and
understanding of these experiences. It was decided that purposeful, maximum variety
sampling would be used to select participants who were positively diagnosed and living
with hepatitis C. Purposeful selection allows the sample to be information rich (Patton,
1990), while selecting participants from a large variety of backgrounds will increase the
transferability of the findings (Nagy & Viney, 1994). The participants were recruited
through the Hepatitis C Council of Western Australia, the Haemophilia Foundation of
Western Australia, and from the general community.
Twelve participants took part in this study, 6 males and 6 females. All
participants lived in the capital city of Perth metropolitan area, and had been positively
diagnosed with the hepatitis C virus. Participant's ages ranged from 23 to 61 years, and
despite the fact that no age limits were placed on the sample, 10 out of 1 2 were middle
aged (37-5 1 years). Four participants were single, six were either married, had partners
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or were in a defacto relationship, and two of the participants were widowed. Seven
participants believed they contracted hepatitis C through injecting drug use, four
believed they contracted the virus through blood transfusions or blood products and one
participant did not say.
Materials
The materials for this study included a semi-structured interview schedule
(Appendix A) and an audio tape recorder. The semi-structured interview schedule was
chosen as a number of advantages using this method of interviewing have been
reported. For example, the semi-structured format facilitates empathy and rapport with
the participants, allows for greater flexibility during the interview process and tends to
produce richer data {Smith, 1995).
The interview schedule included 13 open ended questions that were designed to
elicit discussion about the impacts of hepatitis C at a personal, social and cultural level.
The development of these questions was guided by concepts from the literature and
were also examined by a professional who had extensive experience and knowledge in
the area of hepatitis C, in order to assess whether the questions were appropriate and
adequate. Questions focusing on personal impacts included 'What symptoms, if any,
have you experienced as a result of hepatitis C?' and 'How do you cope with these
symptoms?' Examples of questions that related to social impacts, focused on sources of
support and interpersonal relationships, such as 'What or who are your sources of
support?' and 'How do you think hepatitis C has impacted on you socially?' Questions
designed to explore impacts at a cultural level focused on the time of diagnosis and
aspects of discrimination, for example 'Tell me about your experience of learning that
you have hepatitis C'.
Procedure
With permission of the Hepatitis C Council of WA, advertised invitations
{Appendix D) to participate in the study were placed in newsletters and were distributed

Impacts of Hepatitis C 42

at support groups and public meetings. Advertisements were also placed at the
Haemophilia Foundation of WA and in two local community newspapers. People who
wished to participate were able to call the researcher on the given phone number. Once
contact was made with the participant, a convenient time was set up to conduct the
interviews. Most interviews were conducted at the Hepatitis C Council of WA,
however this was not possible for some participants and in those cases the interviews
were conducted in the participant's home.
Prior to the commencement of each interview, the participant was given an
information letter (Appendix B), which outlined the nature of the study, what they were
required to do, confidentiality, voluntary participation and the freedom to withdraw at
any time. After the opportunity to ask questions or discuss any concerns, informed
consent was obtained (Appendix C) and the interview was conducted and tape recorded.
The interviews took between 25 and 60 minutes to complete and were conversational in
nature. Given the possibility of participants experiencing negative emotions or distress
as a result of sharing personal experiences, referrals to the Hepatitis C Council
Information and Support Line and 24 hour support lines such as Crisis Care, were made
available to all participants. At the completion of the interviews, the audio tapes were
transcribed, coded and analysed by the researcher.
Data Analysis
The data was analysed using a method that focused on analysing qualitative data
from semi-structured interviews (Smith, 1 995). This process involved carrying out a
number of steps for each transcript, in order to understand the content and complexity
of meanings and experiences from the participants' point of view. Each transcript was
read through a number of times and key words, concepts, interesting points and
summaries were recorded to provide a general feel of each participant's experience of
living with HCV. Using these notes, a list of themes was then generated for each
transcript. A question ordered matrix was also used to display key responses to each
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question, with rows representing each participant and columns representing the
interview questions (Miles & Huberman, 1 994). Through using these methods,
similarities and connections between participants were identified, and recurring issues
were organised into a list of master themes and sub-themes that represented the
experiences of participants. The original data was then re-examined and coded for
actual instances of the main themes.
Credibility is described as the extent to which the findings represent the actual
values, feelings and beliefs of the participant and is similar to the concept of internal
validity (Nagy & Viney, 1 994). In order to maintain credibility, emerging themes were
checked against the raw data throughout the analysis process and interpretations were
checked with a number of participants. Reliability was maintained by establishing an
audit trail, which documented details of how the data was analysed, including methods
of data reduction and verification of conclusions (Morse, 1994 ).
Findings
The above method of analysis revealed six main themes, which best illustrated
the experiences of living with hepatitis C and the various impacts associated with the
virus. The main themes were Finding Out, Being 'Infectious', Disclosure, Stigma,
Symptoms and Dealing With It. Each of these themes included a number of sub-themes
and will be discussed below.
Finding Out
The first main theme related to participants' experiences of 'Finding Out' about
their positive HCV diagnosis, and was important because this was the time when the
first impacts of the virus were felt for many people. When asked to tell their story about
how they found out, participants described the way they were told, the information they
were told and how they reacted {Table 1 ).
Most participants were informed that they were HCV positive from doctors or
via blood banks, after they had donated blood. One participant was informed through

Impacts of Hepatitis C 44

the mail. None of the participants knew much about hepatitis C at the time of their
diagnosis and for most it was totally unexpected, suggesting that no pre-test counselling
had occurred. It also seemed evident that in most cases, adequate post-test counselling
was not performed. Participants explained that they either received no information
about HCV whatsoever, very limited information such as 'don't drink alcohol or eat
fatty food', or wrong information such as 'don't have sex', 'don't touch food with out
gloves' or 'if you don't have treatment you will get cancer and die'. This led to
unnecessary stress and anxiety, as people had no idea what HCV was or what it was
going to do to them. Only one participant out of twelve felt they received adequate
information at the time of diagnosis.
Participants' reactions to a positive diagnosis were divided into three types.
There were those who viewed a HCV diagnosis as being 'no big deal' or did not see it
as being an important part of their life at the time. This appeared to be a common
reaction for injecting drug users who at the time had many other stressors in their lives
and did not view HCV as a priority. Some people reacted to HCV with the relief that it
was not HIV, and viewed HCV as 'the lesser of the two evils'. Others felt 'freaked
out', 'shocked', 'stunned', 'devastated', 'frightened' and 'angry' and in some cases
suicidal, often as a result of receiving limited or wrong information. In addition, some
participants were under the impression that HCV was a fatal disease and that they were
going to die, which created significant amounts of stress and anxiety for the individual
and their families.
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Table 1
Responses Relating to Finding Out
"... he said (the doctor) well look, we might as well
Way They Were Told
test you for hep C... and then I got a letter in the mail
saying I was hep C positive...that was it, that was it"
(Pl l)
Information Told

"I was told nothing except that it was a possibly fatal
disease... and he was disapproving and um no
information what so ever actually" (P7)

Reaction to Diagnosis

"It just freaked me out basically that I'd got it and
there was no cure and I'd have to have
treatment...um... and it
just totally stunned me
yeah."(Pl)

Being 'Infectious'
A positive diagnosis of hepatitis C immediately impacted on participants in that
they were suddenly aware that they had a transmissible virus and were able to 'infect'
other people. 'Being 'infectious' ' and the associated implications, was another theme
that reflected participants' experiences of hepatitis C (Table 2). One of the biggest
concerns for participants was the fear of transmitting the virus to somebody else and the
constant worry of people coming into contact with their 'infectious blood'.
The fear of transmission impacted considerably on many aspects of the
participants' lives. Some people left their place of employment because they were
afraid they were placing people at risk by staying at the workplace. Others reported that
it had affected the relationship with their past or current partners by causing strain and
tension, particularly when they cut themselves or when having sex. The fear of
transmitting HCV to family members and particularly children resulted in a significant
amount of stress and people described becoming extremely vigilant in keeping things
clean and hygienic. In some cases, participants felt that they shouldn't go and visit
family members with children because they didn't want to infect them. Being pregnant
and transmitting to future children were also huge concerns for a number of both male
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and female participants, even though they were aware of the relatively low risk
associated with mother to child, or household transmission.
Another impact associated with being 'infectious', was participants' sudden
awareness of being different to everyone else because they had ' bad blood'. This
seemed particularly relevant for those people who were regular blood donors and found
out via the blood banks. A diagnosis of HCV immediately meant that they could no
longer donate blood, which led to feelings of exclusion or unworthiness. It was also
reported that the simple event of cutting a finger, or the presence of even a minute
amount of blood served as a reminder that they had this infectious virus and therefore
were different to others. Some participants described feeling 'dirty and degraded'
because they had this ' yucky type of virus' and in some cases felt isolated or like they
were the 'odd one out'.
Table 2
Responses Relating To Being ' Infectious'
Fear of Transmission
"It's affected me and my partner on so many levels,
it's stolen my sex life, hepatitis C has stolen it, what
can I say.. .it took it away and still now I'm trying to
get it back together" (P9).
"I think there's a two year period where you don't
know if you've passed it on to your child... I hate to
think that I've started a life off with that as well.
(P IO).

"I'm a qualified butcher and I can't work as one any
more... I just stopped working because I was rather
concerned.. .I'm just very, very careful." (P1 3)
Bad Blood

"Oh the other thing that upset me was that for all these
years my husband had gone and given blood every six
months, and when they told me I had hep C they
scrubbed him off the blood bank and said we no
longer want you"(P12).
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Disclosure
One of the areas that appeared to impact greatly on participants was the third
main theme of 'disclosure'. Participants' views on disclosure were basically divided
into two categories, those who did not disclose their HCV status to certain people, and
those who did. The reasons why participants did not disclose were mainly due to the
fear of a negative reaction, whereas those who felt they should disclose did so in order
to keep people safe and to warn others of the risk of transmission (Table 3).
The issue of deciding whether to disclose positive HCV status to someone was a
significant source of stress and uncertainty for the majority of participants. There
appeared to be a dilemma between telling someone due to the fear of transmission, and
not telling them due to the possibility of negative consequences. This internal conflict
was particularly highlighted in relation to telling current or future partners. While most
participants felt that partners should know about their HCV status, disclosing posed the
risk of rejection or some other negative reaction, which is closely linked to the stigma
associated with hepatitis C. For some people, the fear of negative reactions had led to
feelings of loneliness and isolation, as they were scared to get close to people.
In addition to choosing whether or not to disclose, another source of stress
involved knowing when to tell, how to tell and what to tell, and there was a lot of worry
and confusion surrounding this issue. When asked about their experiences of
disclosure, participants described both positive and negative reactions from different
people. For example, some people found that telling friends or family members
resulted in greater levels of support, while others experienced the ending of friendships
or relationships as a result of disclosure. In addition, for the people who contracted
HCV through injecting, disclosure would often mean revealing a history of injecting
drug use, which in turn brought out feelings of shame and fears of being judged or
rejected.
One significant area of uncertainty and mixed feelings appeared to be whether or
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not one should disclose to health professionals. While some participants felt it was their
responsibility to inform doctors and dentists of their status, others felt that doctors,
dentists and nursing staff should be protecting themselves anyway, and they shouldn't
have to inform these people that they were HCV positive because of the stigma
attached. Nevertheless, a number of participants were severely chastised and labelled as
'irresponsible' by certain health professionals because they had not revealed their status
immediately, and therefore had 'put all the staff at risk'. One participant described the
experience as:
" ...the doctor talked to me like a piece of shit cos I didn't volunteer that I
had the virus...they took my blood before I could tell them anyway and
afterwards they came and asked me why I didn't tell them and how I got it
and made me feel shit-house." (Pl )
These experiences most commonly led to feelings of shame or anger and often
increased already high levels of stress and anxiety for these participants.
Table 3
Responses Relating to Disclosure
"If there wouldn't be the possibility of negative
Fear of Negative Reaction
reactions then you'd feel pretty comfortable...but you
know there would be negative reactions so you just
keep it to yourself, you know?" (PS).
"...she wants to know but I don't know whether to tell
her, I think she would accept it but I'm not sure .. .l've
worked on this relationship and I don't want to lose
it." (P4)
Keeping People Safe

"I always felt that why shouldn't I tell somebody if
there's a chance they could get it from me, why
shouldn't I tell them?" (P 1 2)
"I do warn people, if I'm not asked directly and there
is a concern for the other person, I'll always say 'yep
I've got it' " (P13)
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Stigma
One of the most salient themes to emerge among participants was the stigma
associated with HCV and the impacts that were experienced as a result (see Table 4).
All participants had either directly encountered the effects of stigma via discriminatory
actions, or were acutely aware and subject to negative community attitudes linked with
HCV. The range of settings in which participants experienced discrimination was wide,
including the workplace, police, dentists and the church. However for these
participants, discrimination was most often experienced within health care settings.
Some examples included a doctor announcing the participant's HCV status in front of
the rest of the hospital ward, the use of different medical equipment and postponing
medical surgery due to positive hepatitis C status.
Negative attitudes towards HCV were largely perceived as being related to the
stigma associated with injecting drug users or the lack of education about the nature of
HCV. Participants had experienced negative or judgemental attitudes from different
people in the community, including family, friends and doctors, and described feelings
of being 'looked down upon' or like 'everyone was judging' them. These negative
attitudes were often associated with feelings of shame or low self-esteem, and in some
cases led to the termination of friendships or reluctance in asking for health advice.
The stigma associated with injecting drug users was particularly emphasised
when participants talked about the distinction between whether they contracted the virus
through injecting or blood transfusions. Blood transfusions were viewed more
favourably, which was related to the idea that contracting the virus was beyond the
person's control, whereas a diagnosis ofHCV through injecting was seen as being self
inflicted and was more likely to be linked to negative attitudes and stigma. However
participants from both groups reported being subject to the stereotypes of hepatitis C
being a 'junkie's disease' and 'all people with hepatitis C must be drug users'.
Participants also linked the stigma associated with HCV to the general
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community's lack of education about the nature of the virus. This lack of knowledge
led to unnecessary levels of fear about transmission, often as a result of seeing HIV and
HCV as the same virus, therefore raising the same levels of fear and stigma. A number
of participants thought that the key to reducing the level ofHCV related stigma in the
community was to increase awareness and education surrounding hepatitis C so there
would be less fear.

Table 4
Responses Relating to Stigma
Experiences of Discrimination

" ... the thing I remember is being prodded and
poked...a guy tried to unbutton my shirt with a pen
because they didn't want to touch me" (P6).
"Oh well, I mean he used to use a standard metal tray
... but for me he'd bring out the disposable tray so he
could throw it away, that sort of thing" (Pl l ).

Stigma Related to Injecting

"Well just that in hospital they told me you know
you've got hep C and how did you get that...l just got
treated like a junkie...in my case I'd rather keep quiet
or say I got it through a blood transfusion, there's a
stigma attached to it." (Pl )

Negative Community Attitudes "Just the way they look down their nose at you,
maybe not what they say but the delivery of what they
say is more than just blatant and obvious... you kind of
squirm out and feel like scum" (P5).
Lack of Education

''Now if the public could have some knowledge about
transmission, they'd be less scared of us, there'd be
less stigma" (P6)
"What worries me the most is the people who don't
understand the true facts about hepatitis C" (P1 3)
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Symptoms
A number of impacts were highlighted within the theme of' Symptoms',
including the physical and psychological symptoms of HCV, treatment and the
ambiguity of the virus (Table 5). Only three participants reported having significant
physical impacts as a result of hepatitis C, with by far the most common symptom being
excessive fatigue. The experience of fatigue led to a number of physical restrictions,
which in turn impacted on relationships and the ability to work. For example the
physical nature of one participant's job led to a slower work rate, which eventually
resulted in the loss of that job.
A positive diagnosis of hepatitis C was also associated with a number of
psychological impacts, particularly to do with self-concept. Some participants believed
that living with HCV led to a more positive self-concept, by caring more about
themselves and others. In some cases, contracting HCV gave participants a reason to
move out of a lifestyle that they believed was no good for them. Others viewed
themselves in a more negative light as a result of contracting HCV and reported feelings
of guilt, anger and depression. It was interesting to note that for those who contracted
HCV through injecting, having the virus was a constant reminder of their past and often
accompanied feelings of shame, regret and self-blame.
Stress, depression and anxiety also seemed to be related to participants'
increased awareness of mortality, which was also linked to the ambiguous nature of the
virus. Many participants were unsure if the symptoms they experienced were due to
hepatitis C or from something else. The uncertainty surrounding the progression of
HCV also appeared to be a factor that increased levels of stress, reflected by concerns
that it was not known how much time was left before the hepatitis C 'got worse'.
Four participants had been on anti-viral treatment and generally found that they
experienced more physical and psychological side effects resulting from treatment, than
from the virus itsel£ Side effects included nausea, fatigue, muscle aches, weight loss,
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thinning hair, aggression and depression. All four participants described treatment as a
negative experience with half of them having to cease treatment as the effects on their
physical and psychological well being were too great. For the other two, although the
side effects had a negative impact, treatment was seen as a form of hope that they could
beat the virus. Treatment and the associated side effects also had huge implications for
the participants' relationships, families and ability to work. Relationships had ended
due to the significant strain that treatment had placed on them, and one person was no
longer able to work, leading to financial implications.
Table 5
Responses Relating to Symptoms
"I've been totally drained.. .! would sleep a fair bit
Physical
when I was working I'd just come home and go to bed
and that was it...mainly I'm just physically stuffed"
(P4)
Psychological

"Well it was just the stupidity of it, you know I was so
careful and that one time I wasn't. .. fuck, every time I
go to have a blood test I re-live that night. . .! don't
know why I was so stupid" (P 1 )

Ambiguity of Virus

"I don't know whether next time I go for a liver test
its going to be high and its going to affect me next
year or it's not going to affect me at all' (P1 2)

Treatment

"Yeah the treatment is absolute agony, screws your
head, stuffs up your relationships, but it gives you a
light at the end of the tunnel..." (P4).

Dealing With It
A number of methods were used as a way of coping with living with hepatitis C
and these were reflected within the theme of 'Dealing With It' (Table 6). Participants
had adjusted to living with HCV by attempting to gain some control over the virus.
This was achieved in a number of ways which included educating themselves about
HCV by finding out as much information as possible, and making positive lifestyle

Impacts of Hepatitis C 53

changes such as reducing alcohol intake and eating healthy foods. However, it was
mentioned that not drinking alcohol immediately restricted participants' social lives and
led to negative consequences such as feeling like an outcast.
Table 6
Responses Relating to Dealing With It
"... we gathered up as much as we could (info) ... so we
Gaining Control
learnt a lot about it that way and basically didn't panic
as much" (P13)
Don't Think About It

"I probably don't think about it much any more .. .! just
get on with life and enjoy it" (P12)

Support from Others

" ...that's what the hepatitis group did for me, after the
fourth week I felt like yeah, I'm a worthwhile person
and I'm not alone.. "(P4)

Part of a Journey

"Sometimes I just briefly sit and look at the
experience and most times there is something there
that I can learn from...it's helped uncover the true me"
P9

Some participants did not really dwell on the fact that they had hepatitis C and
saw it as 'no big deal.' Those people chose not to think about it and believed they
should just get on with life and enjoy it. Support from others was seen as extremely
important for some people and most support was given by family and friends. A
number of people found the greatest support came from others who were also living
with hepatitis C, whether it be people who were already in the participant's social circle,
or through support groups. Finally, a number of people had developed a very positive
view of hepatitis C and saw it as part of their life journey. Living with HCV was
described as a learning experience, which had resulted in both personal and spiritual
growth.
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Discussion
The purpose of this study was to examine the experiences of people living with
HCV and explore the physical, psychological and social impacts of the virus. The
:findings suggest that a positive HCV diagnosis results in a wide range of interrelated
impacts which affect many aspects of an individual's life. Using a systems framework
similar to that developed by Bronfenbrenner (1 979), it appears that HCV impacts on the
personal, social and cultural environments of an individual. In addition, the results
suggest that external factors within different levels of the system, also impact on an
individual's experience of living with HCV (Figure 1 ). These findings support and
further strengthen the socio-cultural view ofHCV reported by a number of researchers
(Hepworth & Krug, 1 999; Glacken et al, 2001 ).
Cultural Level
stigma
Social Level

education
community awareness

Figure 1 . Participants' experiences of the physical, psychological and social impacts of
HCV, using a systems perspective.

Most research to date has focused on the impact ofHCV at what could be
described as the personal level of the system, often reporting a significant decline in
physical health or psychological well-being (Foster et al, 1 998; Loveday, Deakin &
Neophyton, 1 999). Interestingly, the physical impacts of HCV were not of great
concern for the people in this study, with the majority of participants not experiencing

_.

Impacts of Hepatitis C 55

any physical symptoms at all. This finding is noteworthy given that most information
and research available on HCV focuses primarily on the physical symptoms of the
virus. Furthermore, the majority of information or advice that was given to the
participants at the time of diagnosis by doctors' or other health professionals was
largely to do with the physical effects ofHCV. Results from this study suggest that
physical decline in health is not always an issue for people living with HCV.
In contrast, the greatest impacts at a personal level for participants in this study
appear to be psychological effects such as high levels of stress, feelings of anxiety, and
negative self concept. However, it is interesting to note that this impact on
psychological health does not only result directly from aspects of the virus itself, but
also appears to be significantly influenced by external factors from within the
individual's social and cultural environment. For example, the progression of the HCV
virus is very ambiguous and the uncertainty that is associated with this can lead to high
levels of stress and anxiety. However, factors at a social level such as the information
given when diagnosed, reactions from family and friends, concerns about disclosure and
transmission were more likely to directly influence individuals' levels of stress, anxiety
and self concept.
Research by Glacken et al (200 1 ) suggests that a HCV diagnosis is not an
isolated, personal experience that impacts only on the individual's physical and
psychological health, but one that immediately affects the lives of family and friends.
The findings from the present study further support this research as it indicates that a
positive HCV diagnosis has a far greater impact at a social level. Not only did
participants report immediate effects on family and children due to fear of transmission,
but were also very concerned about how HCV had affected their relationships,
workplace and how to disclose to other people.
External factors at a social level also appear to greatly influence an individual's
experience of living with HCV and subsequent quality of life. It has been noted
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previously that the reactions of family, partners, work colleagues and friends to a HCV
diagnosis can significantly impact on the psychological health of the person with the
virus. In addition, the level of support that an individual has in their social environment
can positively impact on a person's experience ofliving with HCV.
Another factor within the social environment that significantly impacts on an
individual's experience of living with HCV is the quality of pre and post test
counselling given by doctors or other health professionals. Pre-test and post test
counselling is designed to reduce the impact of a positive diagnosis by providing
sufficient information about possible outcomes, educating the person on the risk of
transmission and ensuring that there is adequate support available (McCoy, Watson &
Kosky, 1999). Unfortunately, this study supports findings by others who have
suggested that the numbers of people who actually receive this counselling are minimal
(Crossen et al., 1999; Burrows & Bassett, 1996). It is clear in this study that a large
amount of unnecessary stress and anxiety was directly influenced by a lack of
information, lack of preparation and misinformation given before and after the
diagnosis.
While a positive diagnosis ofHCV does not appear to impact on an individual's
cultural environment per se, results from this study clearly suggest that external factors
within the cultural environment significantly impact on the experience of living with
HCV. Discrimination and stigma associated with HCV appear to be over-arching
cultural factors which have extensive negative social and psychological impacts for
people living with the virus. Stigma within the community appears to negatively impact
on the individual's social networks including family, relationships, friends, work and
can be directly related to the issue of disclosure. This in turn can lead to social isolation
due to the fear of discrimination, and a negative view of the self due to rejection and
being subject to stereotypes. It also seems evident that most people with HCV are
subject to the stereotype of being a 'junkie' or 'druggie', despite whether they
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contracted it through injecting drug use or not, which suggests that there is a significant
lack of community awareness and education surrounding the nature of HCV and how it
is transmitted.
Perhaps one of the more surprising findings was the extent to which people are
subject to discrimination and judgmental attitudes within health care settings, a finding
that has also been reported by a number of other researchers (Crofts, Louie & Loff,
1997; Burrows & Bassett, 1996). One explanation for these negative attitudes by
doctors and other health professionals could be a lack of training and education on HCV
related issues. Nevertheless, this study further highlights previous findings which
suggest that dealing with negative community attitudes and discrimination is often an
everyday reality for people living with HCV (Ward, Colebome & Fort, 2000).
The qualitative approach adopted in this study was the most appropriate method
to seek understanding of personal experiences. It is acknowledged however that this
method of inquiry results in some limitations of the study. The findings reported in this
study reflect the experiences of the participants and cannot be generalised to every
person who has hepatitis C. In addition, it is noted that analysis of qualitative data is
somewhat subjective and reflects the author's interpretations of the participants'
personal experiences. To further strengthen the findings of this study, future qualitative
research is needed to explore the impacts ofHCV, perhaps using a less structured
interview schedule. Despite these limitations, the value of this qualitative research is
significant as it provides a rich and detailed insight into the range of social and cultural
impacts associated with hepatitis C, which other methods may fail to recognise (Miles
& Hubermann, 1994).
Interestingly, the wide range of personal, social and cultural impacts reported in
the present study, create a number of implications for health and helping professionals,
the general community and makers of government policy. Providers of health care
and/or support to people with HCV need to shift their focus from a view in which the
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virus primarily impacts on physical health and psychological well being, and begin to
adopt a more holistic approach towards the ways that HCV impacts on a person's life.
There needs to be awareness that people living with HCV may have other concerns
other than those that are health related and need support regarding issues such as
disclosure, relationships, having children, transmission and dealing with discrimination.
In addition, doctors and other health professionals should be aware of standard pre-test
and post-test counselling guidelines and need to adhere to them, given the negative
consequences that are associated with the lack of information or misinformation at the
time of diagnosis.
Furthermore, there are a number of serious implications for health professionals,
as well as the general community, surrounding the significant amount of HCV related
stigma and discrimination that is experienced by many people living with the virus.
Discrimination within healthcare settings particularly needs to be addressed as health
professionals are viewed as the people to go to for support and advice in regards to
health issues. If people living with HCV are reluctant to go to doctors for help or
advice out of fear of being judged, the likelihood of people accessing these
professionals is reduced and individual health and well being can be seriously
compromised. Increased training for doctors and education for the community on HCV
issues would potentially raise general awareness, reduce the fear associated with
transmission and help dispel the stereotypes that often fuel judgemental attitudes and
discriminatory behaviours. At a wider community level, government policy makers
need to monitor anti-discrimination laws and make sure that policies are well known
and adhered to in the community.
Studies that examine the extent to which a positive HCV diagnosis impacts on
various aspects of a person's life are relatively few and although important findings
have been documented, there is still a great deal of scope for future research. An
interesting next step from the present study would be to conduct a quantitative study
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that assesses these results with a larger number of participants, to see if the findings
could be generalised to a larger population. In addition, HCV related stigma and
discrimination is clearly a significant issue for people living with the virus and ways to
reduce judgemental attitudes and behaviour need to be addressed in future research. It
would also be interesting to conduct a study that examines health professional's
attitudes and knowledge towards HCV related issues, given the extent of discrimination
in health care settings. Finally, future research could also begin to focus on the
potential impacts that a positive HCV diagnosis has on family members, partners and
children of people who are living with the virus.
In conclusion, it seems that a more holistic view of HCV needs to be adopted to
provide adequate care and support for people living with the virus. It appears that the
physical symptoms of the virus itself and potential decline in health are not necessarily
perceived as the biggest impacts of HCV. In contrast, the most distressing impacts can
arise from the psychological and social effects ofliving with a stigmatised, infectious
illness and dealing with the subsequent attitudes and reactions within the immediate
social environment and wider community.
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Appendix A
Interview Schedule
The following interview schedule can be used as a guide. The questions do not
necessarily have to be asked in the presented order.
A : Background

1 . To start with can you tell me your age, sex, and marital status.
2. When do you believe you contracted hepatitis C?
3. How do you believe you contracted hepatitis C?
B: Impacts at Individual Level

4. What symptoms, if any, have you experienced as a result of hepatitis C?
Prompt questions include
- Physical?
- Psychological?
5. How do you cope with these symptoms?
6. Is there anything that you find you could do before, that you can't do now?
7. Has having hepatitis C made a difference to the way you see yourself as a
person? If so, in what way?
C: Impacts at Social/Interpersonal Level

8. What or who are your sources of support
9. How does that help you?
10. How do you think that hepatitis C has impacted on your life socially?
Prompt questions include
- family?
- friends?
- work?
- relationships
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D: Impacts at Cultural Level

1 1 . Tell me about your experiences of learning that you have hepatitis C.
Prompt questions include
- How were you informed?
- What information did the doctor/ health professional tell you?
- How did you feel/ react?
1 2. Can you tell me about any other ways that hepatitis C has had an impact on
your life?
- discrimination?
1 3. Is there any thing else you would like to share about your experience of
living with hepatitis C?

Appendix B 66
Appendix B
Participant Information Sheet

Information Sheet
My name is Narelle Cockman and I am a volunteer at the Hepatitis C Council
of WA, as wel l as a fourth year university student at Edith Cowan
University. I am currently conducting research with people who are living
with hepatitis C and am particularly interested in the impacts that
hepatitis C has on different aspects of a person's life. This research has
been approved by the Edith Cowan School of Psychology Ethics Committee.
The research will involve taking part in a tape recorded interview with
myself, to share your experiences of living with hepatitis C. No names wi l l
be recorded o n the tapes. The interview should take approximately one
hour of your time. The aim of this research is to identify personal and
social impacts of hepatitis C and will hopefully lead to further knowledge,
better understanding and support for people l iving with hepatitis C.
I understand that some issues will be potentially sensitive for some people
so please be assured that any information that you share during the
interview will be held in the strictest confidence. An independent person
will be helping out with the transcribing of the interviews, however your
name will not be on these tapes. Responses and quotes may be used as part
of a thesis but at no time wi ll your name be reported. At the conclusion of
this research, a report on the findings wi ll be available upon request.
Your participation in this research is total ly voluntary. You are not obliged
to answer any particular question and may withdraw from the research at
any time, without consequences. Referral to the Hepatitis C Information
and Support Line and Crisis Care is also available at any time.
Please keep this information letter for your reference. If you have any
questions or concerns about this research, you can contact myself (Narelle
Cockman) on 0418 918 028, or my supervisor Lis Pike at the School of
Psychology on 9400 5535.
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Appendix C
Participant Consent Form

Informed Consent
I (the participant) have read and understand the information sheet and any questions I
asked were answered to my satisfaction. I agree to voluntarily participate in this
research and realise that I may withdraw at any time. I also understand that the findings
will be reported and I will in no way be identifiable.
Participant.____________ l)ate _______
Researcher ----------- l)ate -------
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Impacts of Hepatitis C
How Has Hapatlli C lapactad On Y• Ufe 7
lllla?
Fatigue?

llllallanrllipl

DIICllnmtlon?

..

I am a volunteer at the Hepatitis C Council ol WA and a
loartb year university student. I am very interested
in hearlna about your ezperlenees ol hepatitis C lor my
research. D you are Interested in sbarlna your
ezperlenees with me in a eonlldentlal tape recorded
interview, I would love to bear lrom youm
Please eontaet me, Narelle Coelcman on 9378 928••

